Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_3
2
22%
Ph phase_4
3
33%
Ph phase_2
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Completed5
unknown2
Suspended1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 43 (33.3%)
N/A3 (33.3%)

Trials by Status

unknown222%
suspended111%
withdrawn111%
completed556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9